Patent details

EP3143004 Title: AMORPHOUS FORM OF APREMILAST

Basic Information

Publication number:
EP3143004
PCT Application Number:
IL2014050658
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148920309
PCT Publication Number:
WO2015173792
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AMORPHOUS FORM OF APREMILAST
French Title of Invention:
FORME AMORPHE D'APRÉMILAST
German Title of Invention:
AMORPHE FORM VON APREMILAST
SPC Number:

Dates

Filing date:
20/07/2014
Grant date:
02/09/2020
EP Publication Date:
22/03/2017
PCT Publication Date:
19/11/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/09/2020
EP B1 Publication Date:
02/09/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/07/2021
Expiration date:
20/07/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/08/2020
 
 

Name:
Mapi Pharma Limited
Address:
16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona, Israel (IL)

Inventor

1

Name:
MAROM, Ehud
Address:
Israel (IL)

2

Name:
RUBNOV, Shai
Address:
Israel (IL)

Priority

Priority Number:
201461991528 P
Priority Date:
11/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4035; C07D 209/44;

Publication

European Patent Bulletin

Issue number:
202036
Publication date:
02/09/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages